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Background: Live imaging provides an essential methodology for understanding complex and dynamic cell
behaviors and their underlying molecular mechanisms. Genetically-encoded reporter expressing mouse strains are
an important tool for use in live imaging experiments. Such reporter strains can be engineered by placing
cis-regulatory elements of interest to direct the expression of desired reporter genes. If these cis-regulatory
elements are downstream targets, and thus activated as a consequence of signaling pathway activation, such
reporters can provide read-outs of the signaling status of a cell. The Notch signaling pathway is an evolutionary
conserved pathway operating in multiple developmental processes as well as being the basis for several congenital
diseases. The transcription factor CBF1 is a central evolutionarily conserved component of the Notch signaling
pathway. It binds the active form of the Notch receptor (NICD) and subsequently binds to cis-regulatory regions
(CBF1 binding sites) in the promoters of Notch responsive genes. In this way, CBF1 binding sites represent a good
target for the design of a Notch signaling reporter.
Results: To generate a single-cell resolution Notch signaling reporter, we used a CBF responsive element to direct
the expression of a nuclear-localized fluorescent protein. To do this, we linked 4 copies of a consensus CBF1
binding site to the basal simian virus 40 (SV40) promoter, placed this cassette in front of a fluorescent protein
fusion comprising human histone H2B linked to the yellow fluorescent protein (YFP) Venus, one of the brightest
available YFPs. We used the CBF:H2B-Venus construct to generate both transgenic embryonic mouse stem (ES) cell
lines and a strain of transgenic mice that would report Notch signaling activity.
Conclusion: By using multiple CBF1 binding sites together with a subcellular-localized, genetically-encoded
fluorescent protein, H2B-Venus, we have generated a transgenic strain of mice that faithfully recapitulates Notch
signaling at single-cell resolution. This is the first mouse reporter strain in which individual cells transducing a Notch
signal can be visualized. The improved resolution of this reporter makes it ideal for live imaging developmental
processes regulated by the Notch signaling pathway as well as a short-term lineage tracer of Notch expressing cells
due to the perdurance of the fluorescent reporter. Taken together, the CBF:H2B-Venus mouse strain is a unique tool
to study and understand the morphogenetic events regulated by the Notch signaling pathway.
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The Notch signaling pathway is one of the key signaling
pathways employed during embryonic development,
homeostasis and disease progression (reviewed in [1,2]).
Though first discovered in Drosophila, the Notch path-
way is evolutionary conserved across many metazoan
species playing an important role in various processes
including cell fate specification, differentiation, tissue
patterning and homeostasis, as well as stem cell self-
renewal (reviewed in [1] [2]).
The core components of the Notch signaling pathway
include the Notch transmembrane receptors, Notch1-4
in mammals, and their five canonical membrane-bound
ligands of the Delta or Serrate/Jagged family, Jagged1-2,
and Delta1, Delta3 and Delta4 in mammals. Notch pro-
teins are single-pass transmembrane proteins consisting
of an extracellular domain (NECD), encompassing 29–
36 tandem epidermal growth factor like repeats, a
shorter membrane-spanning region and an intracellular
domain (NICD) containing a transactivation domain
(reviewed in [1]).
Cell-cell contact and the interaction of the NECD with
one of the ligands expressed by a neighboring cell leads
to a cascade of proteolytic events involving an S2 cleav-
age of the Notch receptor, and a cleavage at the S3 site
by γ-secretase. This series of proteolytic cleavages results
in the release of the NICD from the membrane. Thus,
upon signaling the NICD translocates to the nucleus
where it binds the transcription factor CBF1 (also re-
ferred to as RBPJκ, CSL or Su(H)). The binding of NICD
to CBF1 replaces co-factors of the Groucho family that
function to repress target genes and in doing so allows
the recruitment of the co-activator mastermind-like
(MAML) promoting the formation of a CBF1-NICD-MAML
complex that leads to transcriptional activation of target
genes including members of the Hes and Hey families of
bHLH transcription factors [1].
Transgenic reporters providing in vivo read-outs of
Notch signaling activity have been useful for investigat-
ing the complex functions of Notch signaling across spe-
cies. To date, several transgenic strains of mice have
been established to monitor Notch signaling activity,
each employing slightly different construct designs, but
all based on the use of Notch-responsive elements driv-
ing the expression of a readily detectable genetically-
encoded reporter. Of these, a transgenic mouse line,
named NAS (for Notch Activity Sensor), used the TP1
minimal promoter (comprising 12 multimerized CBF
binding sites), which is transactivated in a CBF/RBPJκ-
dependent manner by the NICD and in doing so func-
tions as a read-out of Notch activity. The NAS reporter
comprised a modified version of the lacZ gene coding
for nuclear ß-galactosidase under the control of TP1.
Faithful expression regulated by Notch signaling wasdemonstrated by loss of reporter activity in CBF mutants
[3]. Another transgenic mouse line, CBF:EGFP, used EGFP
as a reporter gene driven by the basal simian virus (SV40)
promoter and a CBF1-responsive element containing four
CBF1 binding sites. The CBF:EGFP strain has been used
to investigate Notch signaling in a variety of contexts,
including neural stem cells and intermediate neural pro-
genitors during mouse neural development. Faithful re-
sponsiveness of the CBF:EGFP to Notch signaling activity
was demonstrated using an shRNA mediated knock-down
of CBF1 and the γ–secretase antagonist F18 [4].
A recent report developed a construct based on the
promoter of the Notch target gene Hes5-1, coupled with
a destabilized nuclear-localized Venus fluorescent pro-
tein and the 3’ untranslated region of Hes5-1. Using
transient transgenesis by electroporation, this Notch sig-
naling reporter was used in chick embryos to investigate
endogenous Notch activity during neurogenesis. Highlight-
ing the importance of single-cell resolution reporters to
understand cell fate and lineage decisions, this reporter re-
vealed distinct Notch signaling dynamics in different cell
division modes in neural progenitors within the neuroepi-
thelium [5].
Another report presented an alternative strategy to the
use of transcriptional reporters as read-outs of Notch sig-
naling activity that could also be used for monitoring
Notch activation in real-time in living cells. In this newly
described reporter Notch activity was recorded in a cell
culture system using a luciferase complementation-based
reporter that could directly monitor interactions between
a specific NICD and CBF/RBPJκ, thereby allowing the
non-invasive detection of protein-protein interactions in
any subcellular compartment [6].
Since the available Notch reporter mouse strains either
lack sensitivity or do not provide single-cell resolution
read-outs, we sought to generate an improved reporter
that would provide single-cell resolution reporter activity,
as a key in understanding cell dynamics and behaviors,
and greater sensitivity by incorporating a nuclear-
localized bright fluorescent reporter, which could be
readily detected, live imaged and quantified. To do so,
we designed a construct that combined the signaling
read-out efficiency of the multimerized CBF1 responsive
elements [4] with an improved nuclear-localized fusion
to a bright fluorescent protein. Fluorescent proteins
fused to histones are bound to chromatin even during
cell division, therefore allowing the tracking of single
cells and their progeny, as well as providing information
on cell division and cell death [7,8]. We generated an
H2B-Venus fusion protein, comprising human histone
H2B fused to the bright yellow fluorescent protein
Venus, and placed it under the control of four CBF1
responsive elements and the simian virus 40 (SV40)
minimal promoter in a configuration resembling the
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[4]. We used this construct to generate CBF:H2B-Venus
transgenic mouse ES cells and an equivalent strain of
mice. In this way the CBF:H2B-Venus transgene was
designed to function as a sensitive single-cell resolution
reporter of Notch signaling, and would be comparable
to the TCF/Lef:H2B-GFP single-cell resolution reporter
we previously generated as a read-out of WNT/β-
catenin signaling [9].
We recovered several founder transgenic lines, which
recapitulated the spatio-temporal localization of Notch
signaling activity during mouse embryonic development,
as well as in adults showing among others expression in
the headfolds, neural tissue of the early embryo, the vas-
culature, the kidney, and brain. One was analyzed in de-
tail and is presented here. Overall, expression of CBF:
H2B-Venus recapitulated the previously reported CBF:
EGFP localization including the expression in the ven-
tricular zone (VZ) and sub-ventricular zone (SVZ) re-
gions of the cortex of the brain [4]. We confirmed
Notch signaling specificity of the reporter, both in cells
and in embryos, through Notch signaling stimulation
achieved by misexpression of NICD leading to reporter
activation.
The CBF:H2B-Venus reporter strain produced bright
single-cell resolution reporter activity. Notch responsive-
ness of the CBF:H2B-Venus reporter was demonstrated
through reporter activation by transfection of an NICD
expression construct in mouse embryo fibroblast (MEF)
cells derived from transgenic embryos, and electropor-
ation into the visceral endoderm of early post-
implantation embryos. Due to its improved sensitivity,
the CBF:H2B-Venus reporter revealed additional sites of
Notch signaling activity, that have previously not been
described, including expression in the epiblast (EPI) of
the peri-implantation mouse embryo. Collectively, these
data demonstrate that we have generated a transgenic
mouse strain that faithfully reports Notch signaling ac-
tivity and serves as a quantitative, non-invasive single-
cell resolution reporter of Notch signaling. The CBF:
H2B-Venus reporter currently represents an improved
tool for imaging the in vivo processes triggered by ca-
nonical Notch signaling.
Results and discussion
Generation of CBF:H2B-Venus reporter construct
Several cis-regulatory elements necessary for Notch signal-
ing activated transcription have previously been tested in
characterized Notch reporter lines [3,4], however, none of
these lines provides a single-cell resolution read-out
of Notch signaling activity. To overcome this issue, we
used a previously characterized CBF1 responsive element
to drive H2B-Venus reporter expression. The CBF1-
responsive element (CBFRE) contains four CBF1-bindingsites upstream of the basal simian virus-SV40-promoter
(Figure 1) and has been used in previous studies reporting
endogenous Notch signaling during mouse brain develop-
ment [4]. The CBFRE and the SV40 minimal promoter
were cloned in front of an H2B-Venus reporter cassette to
generate the final construct, CBF:H2B-Venus. We used
this construct to generate transgenic CBF:H2B-Venus ES
cells by electroporation. CBF:H2B-Venus transgenic mice
were generated by pronuclear injection of the plasmid
construct according to standard protocols. Three founder
mice were identified and screened for bright and faithful
expression of the reporter. The characterization of one of
these is presented in this report.
Reporter activation upon Notch signaling stimulation
To test for Notch responsiveness of the CBF:H2B-Venus
construct, and in doing so validate the reporter as a bona
fide Notch signaling reporter, we derived MEF cells from
E13.5 hemizygous transgenic embryos and transfected
them with an NICD expression construct (pCX:NICD) [4]
to activate reporter expression. Subsequent FACS analysis
revealed an increase in fluorescence upon transfection of
pCX:NICD into CBF:H2B-VenusTg/+ MEF cells demon-
strating the Notch responsiveness of the reporter con-
struct (Figure 1).
To validate the reporter in vivo, we electroporated the
pCX:NICD plasmid into the superficial visceral endoderm
(VE) layer of E6.5 CBF:H2B-Venus Tg/+ embryos (Figure 2).
The VE does not normally express the H2B-Venus re-
porter in wild-type embryos. An pCX:mCherry construct,
providing constitutive expression of the mCherry cytoplas-
mic red fluorescent protein was either electroporated
alone (as a control for the electroporation, Figure 2B-B3)
or together with the pCX:NICD plasmid (Figure 2C-D1).
Electroporated and control non-electroporated embryos
were then subject to ex utero culture [10]. Cells receiving
the pCX:mCherry would be readily visualized due to cyto-
plasmic mCherry red fluorescence (Figure 2A), while cells
receiving the pCX:NICD would activate the CBF:H2B-
Venus reporter and be visualized by their nuclear-localized
Venus fluorescence, and cells receiving both pCX:NICD
and CBF:H2B-Venus would exhibit a red fluorescent
cytoplasm and yellow fluorescent nuclei. Indeed, electro-
poration of pCX:mCherry alone did not activate the H2B-
Venus reporter (Figure 2B-B3). By contrast, electroporation
of pCX:NICD did activate reporter expression in cells of the
VE (Figure 2C, C1, D, D1, white arrows in C1, D and D1)
thereby demonstrating the Notch responsiveness of the CBF:
H2B-Venus reporter.
Generation of CBF:H2B-Venus transgenic ES cells
Since previous studies have reported that mouse ES cells
express Notch receptors and ligands [11], we investigated
whether the CBF:H2B-Venus transgene was expressed in
Figure 1 CBF:H2B-Venus construct design and validation in MEF cells. CBF:H2B-Venus MEFs are derived from E13.5 transgenic embryos and
transfected with a pCX:NICD construct. Ectopic expression of NICD activates the canonical Notch signaling pathway and in turn leads to transgene
expression, which can be assessed using flow cytometry. FACS analysis shows transgenic CBF:H2B-Venus MEFs comprise a Venus negative and
Venus positive population and display an increase in fluorescence upon ectopic NICD expression.
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H2B-Venus transgene was introduced into R1 ES cells [12]
and stable transgenic lines were selected (Figure 3A-A3).
Laser scanning confocal imaging of transgenic ES cells
revealed that the CBF:H2B-Venus reporter was nuclear-
localized in individual cells and overlapped with a
Hoechst nuclear stain (Figure 3A-A1)). The reporter
was present in a subpopulation of ES cells expressing
the pluripotency-associated factors Nanog (Figure 3A2)
and Oct4 (Figure 3A3).
Since it had previously been reported that Notch sig-
naling is involved in regulating the timing of the emer-
gence of the different germ layers in ES cell-derived
embryoid bodies (EBs), we used EB formation to test the
differentiation potential of the CBF:H2B-Venus transgenic
ES cells and determine whether reporter localization
might correlate with the timing of germ layer formation
(Figure 3B-E) [13]. Our results revealed that Notch signal-
ing could initially be detected in EBs cultured until Day
4 (Figure 3B-D). By day 6 however, fluorescence was
downregulated in concordance with progressive differenti-
ation. At this stage tube-like or cystic structures could be
detected within EBs where Notch signaling had been
downregulated (Figure 3E) [14].Collectively, these data indicate that the CBF:H2B-
Venus transgene is a sensitive single-cell resolution
Notch signaling reporter that reveals Notch signaling ac-
tivity in mouse ES cell cultures.
The CBF:H2B-Venus reporter reveals novel sites of Notch
signaling within the early post-implantation epiblast
The robust expression of the CBF:H2B-Venus transgenic
ES cells prompted us to investigate whether the reporter
is also active in the pluripotent epiblast lineage of the
pre-implantation embryo in CBF:H2B-Venus transgenic
embryos. We failed to detect any fluorescent signal within
the inner cell mass of E3.5-E4.5 transgenic blastocysts
(data not shown), suggesting that either the CBF:H2B-
Venus reporter was not sufficiently sensitive for direct
visualization at these stages, or that Notch signaling is not
active in the epiblast lineage at pre-implantation stages.
To further characterize the localization of the CBF:
H2B-Venus reporter and thus the activation of Notch
signaling, we analyzed its distribution in early post-
implantation stages (Figure 3F-I). After implantation
into the maternal uterus around embryonic day (E) 4.5,
the three blastocyst cell lineages (epiblast, primitive
endoderm and trophoblast) are expanded and the axes
Figure 2 Validation of the CBF:H2B-Venus reporter construct in embryos. Schematic of electroporation of a pCX:NICD and pCX:mCherry
construct into the ve of an E6.5 embryo (A). Electroporation of pCX:mCherry into a CBF:H2B-Venus transgenic embryo and subsequent culture
shows expression of mCherry but no reporter activation in the ve (B). Electroporation of pCX:NICD and pCX:mCherry into a CBF:H2B-Venus
transgenic embryo and subsequent culture shows expression of mCherry as well as reporter activation in the ve (C, and D, white arrowheads). Of
note, the ve does not normally express the nuclear-localized Venus reporter, though cytoplasmic fluorescence which is background fluorescence
likely due to fixation of samples is sometimes observed (see Figures 4B and D). mCherry is not localized in the epiblast (epi), these 3D projections
depict reporter expression on the embryos surface in the ve layer (see panels B3 and B1). Cells appear yellow due to strong Venus expression in
epiblast (epi), this bleeds through from the underlying epiblast layer in 3D projections. By contrast, 2D data (see panels B2 and B3) reveal that
there are no green (Venus-positive) cells in ve which comprises only mCherry-positive cells.
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posterior/A-P) are specified at early post-implantation
(~E5.5-E6.0). The visceral endoderm (VE) encapsulates
the pluripotent epiblast distally, and extra-embryonic
ectoderm proximally, and close apposition of these adja-
cent tissues facilitates cross talk between them, resulting
in the formation of the distal visceral endoderm (DVE).
Subsequently, translocation of the DVE population to
generate the anterior visceral endoderm (AVE) leads to
the establishment of the A-P axis (reviewed in [15]).
At the earliest post-implantation stages that we could
recover (~E5.0-5.25), reporter expression was detected in
the epiblast of the CBF:H2B-Venus embryos (Figure 3F,
F1, F2, G, G2, H, H2, I and I2). Expression in the epiblast
persisted until the onset of gastrulation (Figure 3F and
data not shown). In addition, for a very brief window of
time, at around ~ E6.0, reporter expression was detectedin the extra-embryonic ectoderm (Figure 3F). This extra-
embryonic expression was downregulated by ~ E6.5 (data
not shown). Of note, reporter expression in the EPI at
early post-implantation stages looks like a salt-and-pepper
distribution (Figure 3F1), begging the question whether
this distribution represents different cell populations or
whether these could be fluctuations in Notch signaling.
Future studies will address this question. Epiblast-specific
location was confirmed by co-localization with the epiblast
marker, Oct4 (Figure 3H). Localization of the pan-VE
marker Gata6 (Figure 3G), and pan-emVE marker Eomes
in CBF:H2B-Venus embryos revealed that the reporter ex-
pression was excluded from the VE (Figure 3G, I). The
epiblast-specific site of Notch reporter expression has not
been previously reported and may presage the future re-
quirement for Notch signaling and subsequently reporter
expression in neural tissue.
Figure 3 Expression of CBF:H2B-Venus in ES cells and pre-streak stages. Immunostaining of the CBF:H2B-Venus ES cells (A-A3) for
pluripotency-associated factors Nanog (grey) (A2) and Oct4 (red) (A3). Nuclei were stained with Hoechst (blue) (A). Embryoid body formation
from CBF:H2B-Venus ES cells. Fluorescence was assessed after 1, 2, 4 and 6 days of EB culture (B-E). Expression of CBF:H2B-Venus in the epiblast at
E6.0 (F) and E5.5 (G-I). Expression of Gata6 (G1, G2), Oct4 (H1, H2), and Eomes (I1, I2) in CBF:H2B-Venus embryos. At E6.0 CBF:H2B-Venus
expression is detected in the epiblast in a salt and pepper distribution as well as in the extra-embryonic ectoderm (F, F1, F2). At E5.5 CBF:H2B-
Venus expression is restricted to the epiblast (G, H and I). H2B-Venus positive cells express also Oct4 (H2). Note, Gata6 expression in the epiblast
(white arrowhead, G2). Embryo has been counterstained with Hoechst (F1, F2) and Phalloidin (F2) to label nuclei and F-Actin. A, anterior; D,
distal; em, embryonic; ex, extra-embryonic; P, posterior; Pr, proximal. Scale bars: 50 μm.
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cardiogenic region at gastrulation
During gastrulation, which in the mouse takes place be-
tween E6.5 and E8.0, three germ layers, ectoderm, meso-
derm and definitive endoderm, are formed from the
pluripotent epiblast lineage. Mesoderm and definitive
endoderm arise when epiblast cells undergo an epithelial-
to-mesenchymal transition (EMT), and in doing so lose
their epithelial character, ingress through the primitive
streak (PS), which forms at the posterior end of the em-
bryo, and migrate away as the so-called wings of meso-
derm [15,16].
To evaluate CBF:H2B-Venus Notch reporter expres-
sion at gastrulation stages, we examined embryos be-
tween E6.5 and E8.0 (Figure 4). At E6.5 strong reporter
expression in CBF:H2B-Venus embryos was found in the
anterior epiblast, in the prospective headfold region in
contrast to lower level of fluorescence in the posterior
part (Figure 4A-B). At E7.5 the reporter continued to be
strongly expressed in cells of the forming headfolds
(Figure 4C-D), and in cells within the PS region. In the
latter it could be detected in both, epiblast (yellowarrowhead, Figure 4E1) and nascent mesoderm cells
(yellow arrow in Figure 4E1). Reporter expression in
cells in the headfolds persisted until later stages, ~E8.0
(Figure 4F-G). At E8.0 single-positive cells with variable
fluorescent intensities could also be detected in the PS
region of the embryo (yellow arrowheads in Figure 4H1).
In addition, at this stage reporter expression could also
be noted in the cardiogenic plate (Figure 4G and G1, red
arrowhead), in agreement with a previous report in the
chick [17]. Notably, the role of Notch signaling in early
cardiac cells in the mouse is still elusive, whereas its role
in later stages of heart development, especially in valve
formation, has been well documented [18] (see also Notch
reporter expression in the valve in Figure 5D, D1). In the
latter report, Notch1 activity was analyzed using an anti-
body against the N1ICD and could detect expression in
the nascent mesoderm, however in contrast to the CBF:
H2B-Venus reporter, no expression could be detected in
the neuroectoderm [18]. A possible explanation for this
discrepancy could be that the CBF:H2B-Venus reporter is
a transcriptional not translational reporter of Notch sig-
naling activity.
Figure 4 Expression of CBF:H2B-Venus in mouse embryos at E6.5-E8.0. Expression of CBF:H2B-Venus in E6.5 embryos (A-B) showing strong
expression in the anterior epiblast (ae, B, B1). Whole mount view of an E6.5 embryo (A). Transverse section through an E6.5 embryo
(B). Expression of CBF:H2BVenus in E7.5 embryos (C-E). Lateral whole mount view of an E7.5 embryo (C). Transverse section through the anterior
and posterior of an E7.5 (D, D1, E and E1) showing expression in the neural plate (D, D1) and in the primitive streak (ps) region in the epiblast
(yellow arrowhead in E1), as well as in the nascent mesoderm (yellow arrow in E1). Expression of CBF:H2B-Venus in E8.0 embryos (F-H). Lateral
whole mount view of an E8.0 embryo (F). Transverse section through the anterior and posterior section of an E8.0 showing expression in the
headfolds (G and G1), cardiogenic plate (cp, red arrowhead, G1) in the mesodermal layer of the yolk sac (ys, H) and cells in the primitive streak
region (yellow arrowheads, H2). All sections were counterstained with Hoechst to label nuclei. A, anterior; bl, blood islands; D, distal; emVE,
embryonic visceral endoderm; m, mesoderm, P, posterior; Pr, proximal. Scale bars: 100 μm (D, E, G, G1 and H); 50 μm (B, E1 and H1); 30 μm (D1).
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the blood islands (Figure 4F), a cell population of matur-
ing erythrocytes surrounded by developing endothelial
cells that will give rise to the mesoderm layer of the yolk
sac [19], another site of persistent specific and strong
Notch reporter expression (Figure 4H white arrowhead).Surprisingly, we failed to observe expression of the
CBF:H2B-Venus reporter in the presomitic mesoderm
(PSM), a tissue of known and dynamic Notch activity
[20]. However, several previously characterized reporters
have also failed to detect Notch activity at this site of
Notch activity.
Figure 5 Expression of CBF:H2B-Venus at fetal stages (~E14.5). Stereo widefield image of a lateral view of an E14.5 embryo expressing CBF:
H2B-Venus (A). Transverse sections of E14.5 embryo showing CBF:H2B-Venus reporter expression (B1, C1, D1, E1, F1, G1, H1, I1) and CBF:H2B-Venus
expression and Hoechst to label nuclei, respectively (B, C, D, E, F, G, H, I). CBF:H2B-Venus expression at E14.5 in the lens (l) and the pigmented
part of retina (pr) (B,B1). Red arrowhead points to expression in cuboidal epithelium in anterior part of the lens. Red arrow points to Notch
expression in cells of equatorial region of the lens. Expression of CBF:H2B-Venus in the interstitial mesenchymal cells of the lung (C, C1), in cells of
the forming valves of the heart (D, D1), the gut (E, E1), the liver (F, F1) as well as in the vasculature of the digits (G, G1), cells of the thymus (H,
H1) and nasal process (I, I1). a, atrium; br, bronchus; c, cornea; nc, nasal cavity; nr, neural part of retina, v, ventricle.
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to later fetal stages
By midgestation CBF:H2B-Venus reporter expression
was predominantly localized in the vasculature. The
CBF:H2B-Venus reporter was observed in endothelial
cells of the dorsal aorta at E8.5 and at E9.5, as well as in
the umbilical vessels (Figure 6A-C, E and L). Expression
was also detected in the intersomitic vessels (Figure 6Hand O), the pharyngeal arch arteries (Figure 6I and K),
vessels of the head surrounding the neural tube and the
otic vesicle (Figure 6E, J, L and M), as well as in the de-
veloping vasculature of the limb bud (Figure 6O).
We determined that this observed site of reporter ex-
pression was in endothelial cells of the vasculature, by
analyzing the localization of PECAM (CD31) a marker
of endothelial cells in CBF:H2B-Venus embryos and
Figure 6 Expression of CBF:H2B-Venus reporter at E8.5-E9.5 with specific localization in endothelial cells. Expression of CBF:H2B-Venus in
E8.5 embryos (A-C). Lateral whole mount view of an E8.5 embryo (A). Transverse sections through the anterior and posterior regions of E8.5
embryo depicting reporter expression in dorsal aorta (da) (B-C) as well as intermediate mesoderm (red arrowhead, B1). Expression of CBF:H2B-
Venus at E9.5 (D-J). Lateral views of same E9.5 embryo to highlight the plane of section (D, D1, D2, D3). Transverse sections through anterior and
posterior regions of E9.5 embryo depicting reporter expression in da (E, E1, E2, G, G1, G2), head vessels (E, red arrow in E1, E2, J, red arrow in
J1 and J2), umbilical veins (G, G1, G2), intersomitic vessels (isv, white arrow in H, H1 and H2), pharyngeal arch arteries (yellow arrow in I, I1 and
I2) and mesoderm of the pharyngeal arches (pa, I, I1, I2 and I3). Expression of CBF:H2B-Venus counterstained with Hoechst to label nuclei in E8.5
embryo (B, C), in E9.5 embryo (E, F, G, H, I, J). Expression of CBF:H2B-Venus in E8.5 (B1, C1) and E9.5 (E1, F1, G1, H1, I1, J1) embryos. Expression of
CBF:H2B-Venus counterstained with phalloidin to label F-Actin in E8.5 (B2, C2) and E9.5 (E2, F2, G2, H2, I2, J2). Co-staining with PECAM (K-O and
O1), a marker for endothelial cells in E9.5 reveals localization of CBF:H2B-Venus reporter expression to endothelial cells in the pharyngeal arches
(K), dorsal aorta (L), head vessels (L), umbilical veins (M), tail bud (N), intersomitic vessels (O, white arrow) and limb bud (O). IV, fourth ventricle;
hg, hindgut; lb, limb bud; np, neural plate; nt, neural tube; ov, otic vesicle; ppc, pericardio-peritoneal canal; som, somites; uv, umbilical veins.
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Venus (Figure 6K-O). Note, the nuclear expression of
the reporter and membrane expression of PECAM in
the same cells (Figure 6O1).
Localization of CBF:H2B-Venus expression at later
fetal stages (E14.5, Figure 5) revealed reporter expression
in a variety of tissues. In the lens, H2B-Venus could be
detected in cells of the cuboidal epithelium that com-
prises the anterior lens (red arrowhead), as well as in
cells in the equatorial region (red arrow), the region where
anterior capsular epithelial cells become integrated intothe lens-proper and form the lens fibers. In the retina of
the eye, strong expression could be found in the retinal
pigmented epithelium, RPE (Figure 5B and B1). Reporter
expression was also detected in mesenchymal cells of the
lung (Figure 5C and C1), in cells that will form the valves
of the heart (Figure 5D and D1), in cells of the gut
(Figure 5E and E1) and liver (Figure 5F and F1), in the vas-
culature of the digits (Figure 5G and G1), as well as in
cells of thymus (Figure 5H and H1), and in cells surround-
ing the nasal process likely being vascular cells (Figure 5I
and I1).
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To examine the expression and localization of this novel
Notch signaling reporter at postnatal tissues, we dissected
organs of three-week-old animals and analyzed transgene
expression (Figure 7). Strong reporter expression was
found in the interstitial mesenchymal cells of the lung
(Figure 7A, A1 and A2), as well as in the kidney (Figure 7
C and C1) and the adrenal gland (Figure 7D). Robust but
restricted reporter expression, mainly to the vasculature,
was observed in several tissues including the uterus, testis
and pancreas (Figure 7F, F1, G, G1, G2, H and H1).Figure 7 Expression of CBF:H2B-Venus in adult mouse organs. Widefie
(A), heart (B), kidney (C, C1), thymus (E, E1), uterus (F, F1), testis (G, G1), pa
eyeball (O). Laser confocal images of sections through the heart muscle (B
(M, M1) and pituitary (N). Sections are counterstained with Hoechst to labeReporter expression was also detected in cells of the car-
diac and skeletal muscle (Figure 7B, B1 and J). Recent
studies have revealed that Notch signaling is required for
the establishment and maintenance of muscle satellite
cells, confirmation of whether Venus-positive cells are sat-
ellite cells, is outside the scope of the present study and
will be addressed in the future (reviewed in [2] [21]).
Notch signaling has been implicated in T-cell lineage com-
mitment and maturation in the thymus, as well as in T-
cell activation and differentiation (reviewed in [22]). Fluor-
escence indicative of Notch signaling activity was detectedld fluorescent images of CBF:H2B-Venus expression in the adult lung
ncreas (H, H1), spleen (I, I’), Peyer’s patches (K), lymph node (L) and
1), adrenal gland (D), seminal vesicle (G2), skeletal muscle (J), intestine
l nuclei.
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as in cells of the thymus, the spleen, Peyer’s patches within
the intestine, and the lymph nodes (Figure 7E, E1, I, I1, K
and L). Additional sites of CBF:H2B-Venus reporter ex-
pression that can be noted were the intestine (Figure 7M
and M1) and the pituitary (Figure 7N).
CBF:H2B-Venus reporter expression in the kidney
To validate the CBF:H2B-Venus reporter as an improved
tool for visually dissecting morphogenetic processes,
we chose to look at reporter expression in the kidney in
detail. The importance of the evolutionary conserved
Notch signaling pathway is not just illustrated by the fact
that it is indispensable for kidney development across
phyla [23], but it is also involved in the pathophysiology
of congenital diseases, such as the Alagille syndrome
[24,25], glomerular diseases, in tissue repair after acute
renal injuries [26] [27], as well as in the prevention of
renal epithelial cancers [28].
The mammalian kidney develops from the intermedi-
ate mesoderm in three distinct phases, successively
forming the pro-, meso- and metanephros. Whereas the
metanephros will give rise to the adult kidney, the pro-
and mesonephros are vestigial embryonic structures that
will eventually degenerate. The pronephros begins to de-
velop at around E10.5 giving rise to the ureteric bud
(UB), which will invade the metanephric mesenchyme
surrounding it. Bifurcation of the UB and subsequent
branching and elongation will form the collecting duct
system. Reciprocal signaling between the metanephric
mesenchyme and the UB is important to give rise to the
progenitor cells of glomerular and epithelial cells. Since
Notch signaling has been shown to play a key role in
these processes, we analyzed reporter expression in the
developing kidney during metanephros development at
E13.5 and E16.5 (Figure 8A, B, B1 and C, D, D1) as well as
neo- (P0) (Figure 8E, F, F1) and postnatal (P21) stages
(Figure 8G, H and H1). At E13.5 we could detect reporter
expression in the metanephric mesenchyme (Figure 8B,
B1). By E16.5 through postnatal stages, H2B-Venus ex-
pression was observed in the podocytes (Figure 8C, C1).
Notch-2 has previously been reported to be required for
the differentiation of proximal nephron structures, such as
podocytes and proximal convoluted tubules [29]. At
neonatal (P0) stages, H2B-Venus expression was detected
in the collecting duct system as well as in the podocytes
(Figure 8F-F1). In three-week old (P21) animals reporter
expression was exclusively observed in the podocytes
(Figure 8H-H1).
CBF:H2B-Venus reporter expression in the brain
Notch signaling has been intensively studied and shown
to be indispensable for various aspects of neural devel-
opment. Notch signaling has been proposed as a masterregulator of neural stem cells, as well as serving crucial
functions in differentiated cells in the adult brain. We
therefore analyzed the localization of the CBF:H2B-
Venus reporter in the developing brain (Figure 9). Even
though our analysis is not comprehensive, it identifies
areas of Notch signaling in the brain that are in agree-
ment with previously published domains of Notch ex-
pression [4].
In general overview, from embryonic through adult
stages reporter expression was observed in several parts of
the brain including the telencephalon, mesencephalon, the
olfactory bulbs, ganglia, as well as the cerebellum and the
brain stem (Figure 9A-D). The latter two exhibited very
strong CBF:H2B-Venus reporter expression. A more
detailed histological analysis of brain sections revealed
expression at E13.5 in neurons in the cortex (Figure 9E)
and in the choroid plexus (Figure 9F). Reporter expression
was noted in the spinal cord from E13.5 to adulthood, and
is depicted at E16.5 (Figure 9G, G1). We also detected ex-
pression in the hippocampus and the subventricular zone
(SVZ), as well as in the cortex. A particular group of cells
in the cortex at the border of the two hemispheres overly-
ing the corpus callosum exhibited very strong expression
(Figure 9H2). In the cerebellum, shown at P21, robust re-
porter expression was detected in the granular layer,
whereas only a few sparse cells in the cortical layer were
positive for the reporter (Figure 9I, I1). At this stage re-
porter expressing cells, likely neurons, were also detected
in the cortex (Figure 9J, J1). During early embryogenesis,
at E10.5, we also observed CBF:H2B-Venus reporter ex-
pression in the ventricular zone 2 (V2) of the neural tube
(Figure 10, white arrowhead) Expression of Notch and its
ligands in V2 has been previously described [30,31].
Conclusions
We have generated a novel single-cell resolution transgenic
strain of mice that serves as a transcriptional read-out of
Notch signaling. The reporter comprises multimerized
CBF1 DNA binding sites that drive the expression of a
subcellular-localized, genetically-encoded fluorescent fusion
protein, H2B-Venus. We have characterized the expression
of the CBF:H2B-Venus reporter in detail in mouse ES cells,
post-implantation embryos and adult tissues. Specificity of
this putative Notch signaling reporter was demonstrated by
its activation upon transfection with an NICD expression
construct in transgenic MEF cells grown in culture and
in vivo in embryos, as well as by documenting regions of
reporter expression that correspond to those previously
reported as sites of Notch signaling activity. Collectively,
these data suggest that CBF:H2B-Venus reporter expression
acts as a faithful read-out of Notch signaling.
In addition to previously reported sites of expression,
the sensitivity of the reporter identified new sites of
Notch signaling in embryos, in particular within the
Figure 8 CBF:H2B-Venus expression during kidney development. Fluorescent stereo-widefield images of whole mount kidneys at stages
E13.5 (A), E16.5 (C), P0 (E) and P21 (G) showing CBF:H2B-Venus expression. Laser confocal images of transverse sections through the kidney of
stages E13.5 (B, B1), E16.5 (D, D1), P0 (F, F1) and P21 (H, H1) expressing CBF:H2B-Venus. Sections are stained with Hoechst to label nuclei. ag,
adrenal gland; ct, collecting tubules; g, gonad; gl, glomerulus, k, kidney; mm, mesenchymal tissue of medullary region; mv, metanephric vesicle,
p, podocytes. Note, strong expression in the retro-peritoneal lymph sac (rps).
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novel sites of expression are supported by previous ob-
servations of Notch signaling function made in mouse
embryonic stem (ES) cells.
Even though the reporter described in this report pro-
vides a read-out of the transcription resulting from path-
way activation, and is not a read-out of the localization
of one of the core components of the Notch signaling
pathway, we cannot exclude some perdurance of the
fluorescent protein. As such, the complete domain of re-
porter expression, that we have characterized, may en-
compass cells actively signaling as well as those that have
recently been actively signaling but currently not signal-
ing. Future efforts will be aimed at generating more sensi-
tive reporters and will include the development of dualreporters that combine short-term expression, using a
destabilized fluorescent protein with a more perdurant
fluorescent protein as has recently been described in
zebrafish [32].
Even so, the CBF:H2B-Venus reporter is, at present,
the most sensitive reporter of Notch signaling, and due
to the use of the human histone H2B fusion, it allows
the live visualization of individual cells in cohorts. It is
presently the only reporter facilitating the analysis of
cellular dynamics, including tracking of single cells in
Notch responsive populations. Live imaging has become
an essential part of understanding developmental pro-
cesses; therefore this reporter should be a valuable tool
to understand cellular events in development and dis-
ease regulated by canonical Notch signaling.
Figure 9 CBF:H2B-Venus expression during brain development. Epifluorescent widefield images of E13.5 (A, A1), E16.5 (B, B1), P0 (C, C1) and
P21 (D, D1) depicting CBF:H2B-Venus expression in the dorsal (A, B, C, and D) and ventral (A1, B1, C1 and D1) part of the brain. Laser confocal
images of sections through the brain of stages E13.5 (E, F), E16.5 (G, G1), P0 (H, H1, H2, H3) and P21 (I, I1, J and J1) expressing CBF:H2B-Venus
stained with Hoechst and Phalloidin to label nuclei and F-Actin, respectively. Lateral section through the telencephalon of an E13.5 brain (E).
Lateral section through the choroid plexus at E13.5 (F). Transverse section through the brain stem area at E16.5 (G, G1). Frontal sections through
a P0 brain (H, H1, H2, H3). Transverse sections through a P21 brain (I, I1, J and J2). bs, brain stem; cc, Corpus Callosum: ce, cerebellum; cl, cortical
layer; g, ganglium; gl, granular layer; hi, hippocampus; mes, mesencephalon; olb, olfactory bulb; svz, subventricular zone; te telencephalon.
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Generation of Notch reporter constructs and transgenic
animals
To generate the CBF:H2B-Venus construct, a CBF respon-
sive element (CBFRE) including 4 binding sites for CBF1
together with basal simian virus 40 (SV40) promoter was
amplified from the CBFRE:EGFP plasmid (purchased from
Addgene, plasmid #17705), which has been described previ-
ously [4]. The amplified CBF responsive element was then
subcloned into the AseI/NheI sites of pCMV:H2B-Venus.Recombinant clones were confirmed with restriction digest
analysis as well as sequencing. Transgenic mice were gener-
ated by pronuclear injection following standard protocols.
Animals were genotyped by PCR using either of two alter-
native strategies. Primers used for the PCR amplification of
the CBF responsive element (CBFRE, 350bp) were CBF AseI
Fw: GCTGATTAATCGAGATCTGGTGTAAACAC and
SV40 NheI Rev: GCGAGCTAGCCAGCTTTTTGCAAAA
GCCTAG, or alternatively, a 475bp fragment from the
Venus cassette was amplified using primers IMR872 Fw:
Figure 10 CBF:H2B-Venus expression in the V2 zone of the neural tube. Laser confocal images of transverse sections through the neural
tube region of a E10.5 embryo showing expression of CBF:H2B-Venus in the ventricular zone 2 (V2) (white arrowhead, A and A1). CBF:H2B-Venus
expression counterstained with Hoechst to label nuclei (A). CBF:H2B-Venus expression only (A1). nt, neural tube.
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AGGTAGTGGTTGTCG. Several transgenic founder lines
exhibiting comparable expression were identified. One
transgenic founder line (CBF:H2B-Venus #5) was analyzed
in detail and presented in this report. Subsequent genera-
tions exhibited Mendelian transgene inheritance, stable
transgene activity and comparable levels of reporter ex-
pression. The transgene could be homozygozed without
incurring any phenotype. Animals were maintained in ac-
cordance with National Institute of Health (NIH) guide-
lines for the care and use of laboratory animals and under
the approval of the Memorial Sloan Kettering Cancer
Center (MSKCC) Institutional Animal Care and Use
Committee (IACUC).
Generation of transgenic ES cells
The CBF:H2B-Venus construct was tested in R1 ES cells
[33]. R1 ES cells were cultured in standard conditions [34].
Transgenic R1 ES cells were generated by nucleofecting a
FspI linearized CBF:H2B-Venus construct followed by selec-
tion of clones under Neomycin selection according to
standard protocols.
Transfection of MEFs
MEFs were derived from E13.5 transgenic embryos and
passaged 3 times in Dulbecco's Modified Eagle Medium
(DMEM; Gibco) containing 15% serum (Gibco) and 50
mg/mL each of penicillin/streptomycin (Gibco). They were
subsequently seeded onto a 12-well plate (BD Falcon) and
transfected with 2 μg pCX:NICD [4] (purchased from
Addgene, plasmid #26891) using 10 μL Lipofectamine LTX
(Invitrogen) and 2 μL Plus Reagent according to the
manufacturer's protocol. Cells were then cultured for 36 h
and analyzed using flow cytometry.Generation of embryoid bodies (EBs)
ES cells were passaged off MEFs, as previously described
[35], then plated as hanging drops at a concentration of
15,000 cells/mL (300 cells per hanging drop) in Iscove's
Modified Dulbecco Medium (IMDM; Gibco) containing
20% serum (Gibco), 50 mg/mL each of penicillin/strepto-
mycin (Gibco), 200 mg/mL apo-transferrin (Sigma), 5%
protein-free hybridoma medium (PFHMII; Gibco), 0.5
mM 1-thioglycerol (Sigma), and 0.5 mM ascorbic acid
(Sigma). Ebs were harvested after 1, 2, 4 and 6 days of cul-
ture and imaged.
FACS analysis
MEF cells were harvested 36hrs after transfection by
trypsinization with 0.025% trypsin/EDTA (Invitrogen)
and analyzed by flow cytometry using a FACS Fortessa
flow cytometer (BD Biosciences). The live single cell
population was selected for further analysis on the basis
of Forward Scatter (FSC) and Side Scatter (SSC) charac-
teristics as well as with Propidium Iodide (PI) staining to
evaluate cell viability. Histogram plots of the data were
generated using FlowJo (Tree Star, Inc).
Embryo collection and culture
Early post-implantation mouse embryos were dissected in
DMEM/F12 (1:1) containing 5% newborn calf serum and
fixed in 4% paraformaldehyde. E13.5, E 16.5, P1 were dis-
sected in PBS and fixed in 4% paraformaldehyde.
Electroporation and culture of postimplantation embryos
E6.5 embryos were dissected and kept in culture
medium (50% DMEM/F12, 50% rat serum). Then em-
bryos were transferred into a drop of PBS. Highly con-
centrated plasmid DNA of pCX:NICD (purchased from
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added and incubated for 5min. Subsequently, embryos
were transferred into Tyrode’s ringer saline for electro-
poration. Embryos were pulsed using a ECM830
electroporator (BTX, Harvard Instruments). Settings
were as follows: Voltage: 0017V, Length: 050ms; Pulse: 5,
Interval 1s). Embryos were then cultured for 8hrs or
over night in roller culture and then imaged. pCX:
mCherry was generated by PCR of mCherry from
pRSET:mCherry [36] using the 5’ oligo CCGGAATT
CCGGATGGTGAGCAAGGGCGAGGAGGATAAC and
the 3’oligo CCGGAATTCCGGTTACTTGTACAGCTC
GTCCATGCCGCCGGT, both containing EcoRI restric-
tion sites. The resulting PCR product cloned into
pCAGGS [37] using the EcoRI restriction enzyme.
Embryo sectioning
For cryosections, samples were equilibrated in 10% su-
crose in PBS, followed by 30% sucrose in PBS overnight
and OCT (Tissue-Tek) overnight, and then snap-frozen in
OCT. Sections were cut with a Leica cryostat at 12 μm
and counterstained with Hoechst 33342 (Invitrogen) to
label nuclei. Sections were mounted in Fluoromount-G
(Southern Biotech) and imaged through glass coverslips.
Immunostaining
ES cells cultured on coverslips were immunostained as
previously described [38]. Primary antibodies used were:
NANOG (1:200, Cosmo Bio) and OCT4 (1:200, Santa
Cruz). Embryos were permeabilized in 0.5% Triton X-
100 in PBS for 20 minutes, washed in 0.1% Triton X-100
in PBS (PBT) and blocked in horse serum in PBT for
1 hr at 4C. Primary antibodies used were: anti-Eomes
(1:500, Abcam), anti-Oct4 (1:200, Santa Cruz) anti-
Gata6 (1:100, RD Systems) and anti-PECAM (CD31)
(1:250, BD Pharmingen). Secondary Alexa Fluor conju-
gated antibodies were used at a dilution of 1/1000. Nuclei
were visualized using Hoechst (Invitrogen). Phalloidin was
used to label F-Actin.
Image acquisition
Widefield and epifluorescence images were acquired using
a Zeiss Axiocam MRc CCD camera coupled to a Leica
M165FC dissecting scope. Laser scanning confocal data
were acquired using a Zeiss LSM510META or a Zeiss
LSM700 using a Fluar 5×/NA0.25, a PlanApo 10×/NA
0.45 and PlanApo 20×/NA0.75 objective. Fluorophores
were excited using a 405 nm diode laser (Hoechst),
488 nm Argon laser (GFP) or 543 nm HeNe laser (Alexa
546) on the LSM 510 META, and 405 nm (Hoechst),
488 nm (GFP), 555 nm (Alexa 546) solid-state lasers on
the LSM 700.
Embryos and ES cells were imaged in whole mount in
MatTek dishes (Ashland). Confocal images were acquiredas z-stacks of xy images taken at 2 μm z-intervals (20×)
10 μm z-intervals (10×) and 40 μm z–intervals (5×). Raw
data were processed using the Zen 2010 software (Zeiss)
and assembled in Adobe Photoshop CS4 (Adobe).
Endnotes
The CBF:H2B-Venus transgenic strain described in this
report has been accepted for inclusion in, and will be made
available from, The Jackson Laboratory Mouse Repository
as JAX Stock No. 020942 STOCK Tg(Cp-HIST1H2BB/
Venus)#Hadj/J.
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